Oxypoint brings innovation to a 100-year old product. Next to traditional continuous oxygen delivery, Oxypoint adds the on-demand (comfort) mode. With the comfort mode oxygen is only administered to the patient when the flowmeter is being triggered by the patients inhalation.
This type of oxygen administration gives many benefits: •Patient experiences more comfortable oxygen administering. •More flexibility in therapy •Higher therapy efficiency & loyalty •More efficient use of oxygen •Overall lower healthcare cost •Nursing and hospital staff give better care •Overall positive experience for all stakeholders
Oxypoint successfully raises €3.8 million in series A funding
Oxypoint nv, the award-winning University of Antwerp spin-off, bringing innovation to the medical device market for oxygen therapy in hospitals, announced the closing of a €3.8 million Series A financing round. The company will use the proceeds to bring its unique proprietary CE-labelled Econo-Comfort Oxygen Flowmeter™ to the European market.
Oxypoint is an energetic start-up, active in the MedTech industry. Our roots lie firmly with the University of Antwerp, of which we spun out in 2011. With our multidisciplinary team we improve oxygen therapy in hospitals. We have developed a new way to administer oxygen and improve not only patient comfort but also achieve substantial savings for the hospital and the general healthcare costs. We are proud that we can achieve this innovation by bringing together the insights, experiences and creativity of people within an open, stimulating environment.